Thermo Fisher Scientific Inc. (NYSE:TMO) is Sky Investment Group LLC’s 10th Largest Position

Sky Investment Group LLC boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating) by 0.3% in the first quarter, Holdings Channel reports. The fund owned 16,142 shares of the medical research company’s stock after buying an additional 54 shares during the quarter. Thermo Fisher Scientific makes up about 2.0% of Sky Investment Group LLC’s holdings, making the stock its 10th biggest holding. Sky Investment Group LLC’s holdings in Thermo Fisher Scientific were worth $9,534,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. boosted its holdings in Thermo Fisher Scientific by 3.8% in the 4th quarter. BlackRock Inc. now owns 30,982,611 shares of the medical research company’s stock worth $20,672,838,000 after acquiring an additional 1,143,333 shares during the period. State Street Corp boosted its holdings in Thermo Fisher Scientific by 3.4% in the 4th quarter. State Street Corp now owns 16,223,173 shares of the medical research company’s stock worth $10,828,875,000 after acquiring an additional 529,712 shares during the period. Capital Research Global Investors boosted its holdings in Thermo Fisher Scientific by 2.3% in the 4th quarter. Capital Research Global Investors now owns 9,454,032 shares of the medical research company’s stock worth $6,308,097,000 after acquiring an additional 208,075 shares during the period. Geode Capital Management LLC boosted its holdings in Thermo Fisher Scientific by 3.5% in the 4th quarter. Geode Capital Management LLC now owns 6,403,805 shares of the medical research company’s stock worth $4,261,136,000 after acquiring an additional 214,375 shares during the period. Finally, Norges Bank purchased a new position in Thermo Fisher Scientific in the 4th quarter worth approximately $2,784,029,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

In other news, CEO Marc N. Casper sold 2,181 shares of the stock in a transaction on Wednesday, May 4th. The stock was sold at an average price of $562.46, for a total value of $1,226,725.26. Following the completion of the transaction, the chief executive officer now owns 183,373 shares of the company’s stock, valued at $103,139,977.58. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Debora L. Spar sold 200 shares of the stock in a transaction on Monday, May 2nd. The stock was sold at an average price of $544.36, for a total value of $108,872.00. Following the completion of the transaction, the director now directly owns 810 shares of the company’s stock, valued at approximately $440,931.60. The disclosure for this sale can be found here. Insiders sold 42,561 shares of company stock worth $23,557,413 over the last ninety days. 0.43% of the stock is owned by corporate insiders.

A number of equities analysts have issued reports on TMO shares. StockNews.com started coverage on Thermo Fisher Scientific in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Wells Fargo & Company lowered Thermo Fisher Scientific from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $605.00 to $525.00 in a research report on Monday, April 25th. One research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $658.92.

NYSE TMO traded up $12.89 during trading hours on Thursday, hitting $532.11. The company had a trading volume of 26,771 shares, compared to its average volume of 1,216,127. Thermo Fisher Scientific Inc. has a fifty-two week low of $489.14 and a fifty-two week high of $672.34. The company has a quick ratio of 1.10, a current ratio of 1.56 and a debt-to-equity ratio of 0.77. The business has a fifty day simple moving average of $544.31 and a 200-day simple moving average of $575.26. The firm has a market cap of $208.30 billion, a P/E ratio of 27.07, a price-to-earnings-growth ratio of 1.74 and a beta of 0.83.

Thermo Fisher Scientific (NYSE:TMOGet Rating) last issued its earnings results on Thursday, April 28th. The medical research company reported $7.25 earnings per share for the quarter, topping the consensus estimate of $6.17 by $1.08. Thermo Fisher Scientific had a return on equity of 25.33% and a net margin of 18.49%. The firm had revenue of $11.82 billion for the quarter, compared to analyst estimates of $10.66 billion. During the same period last year, the company earned $7.21 earnings per share. The firm’s revenue for the quarter was up 19.3% on a year-over-year basis. Equities analysts forecast that Thermo Fisher Scientific Inc. will post 22.7 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 15th. Shareholders of record on Wednesday, June 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 0.23%. The ex-dividend date is Tuesday, June 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 6.26%.

About Thermo Fisher Scientific (Get Rating)

Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

See Also

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.